Illumina, Ariosa Seek Tens Of Millions As IP Trial Ends
Illumina and Ariosa Diagnostics delivered closing arguments Tuesday in their two-week-long California federal court trial over noninvasive fetal testing technology, with Illumina arguing its rival infringed two patents while Ariosa countered...To view the full article, register now.
Already a subscriber? Click here to view full article